GR3030402T3 - Oesteoblast growth stimulating compostion containing pdgf and vitamin d - Google Patents

Oesteoblast growth stimulating compostion containing pdgf and vitamin d

Info

Publication number
GR3030402T3
GR3030402T3 GR990401332T GR990401332T GR3030402T3 GR 3030402 T3 GR3030402 T3 GR 3030402T3 GR 990401332 T GR990401332 T GR 990401332T GR 990401332 T GR990401332 T GR 990401332T GR 3030402 T3 GR3030402 T3 GR 3030402T3
Authority
GR
Greece
Prior art keywords
vitamin
growth stimulating
containing pdgf
oesteoblast growth
growth
Prior art date
Application number
GR990401332T
Other languages
English (en)
Inventor
Emma E Moore
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of GR3030402T3 publication Critical patent/GR3030402T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1858Platelet-derived growth factor [PDGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/135Platelet-derived growth factor [PDGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR990401332T 1993-03-29 1999-06-03 Oesteoblast growth stimulating compostion containing pdgf and vitamin d GR3030402T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3832593A 1993-03-29 1993-03-29
PCT/US1994/003331 WO1994022463A1 (en) 1993-03-29 1994-03-29 Oesteoblast growth stimulating compostion containing pdgf and vitamin d

Publications (1)

Publication Number Publication Date
GR3030402T3 true GR3030402T3 (en) 1999-09-30

Family

ID=21899306

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990401332T GR3030402T3 (en) 1993-03-29 1999-06-03 Oesteoblast growth stimulating compostion containing pdgf and vitamin d

Country Status (14)

Country Link
US (1) US5533836A (el)
EP (1) EP0691849B1 (el)
JP (1) JP3699111B2 (el)
KR (1) KR960701648A (el)
CN (1) CN1104257C (el)
AT (1) ATE180674T1 (el)
AU (1) AU681879B2 (el)
CA (1) CA2159449C (el)
DE (1) DE69418865T2 (el)
DK (1) DK0691849T3 (el)
ES (1) ES2132399T3 (el)
GR (1) GR3030402T3 (el)
RU (1) RU2140282C1 (el)
WO (1) WO1994022463A1 (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700289A (en) * 1995-10-20 1997-12-23 North Shore University Hospital Research Corporation Tissue-engineered bone repair using cultured periosteal cells
CA2258822A1 (en) 1996-06-20 1997-12-24 Sean Kerwin Compounds and methods for providing pharmacologically active preparations and uses thereof
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6042855A (en) * 1997-06-27 2000-03-28 United States Of America (Usda) Use of vitamin D, its metabolites and analogs to improve tenderness of meat and meat products
EP1043963A4 (en) * 1997-12-31 2001-02-07 Depuy Orthopaedics Inc OSTEOPONTIN-BASED COMPOSITION TO INCREASE BONE FORMATION
US6551355B1 (en) 1998-08-14 2003-04-22 Cambridge Scientific, Inc. Tissue transplant coated with biocompatible biodegradable polymer
US6663870B2 (en) * 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) * 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
WO2001032197A2 (en) * 1999-11-02 2001-05-10 Eli Lilly And Company Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
JP5368102B2 (ja) * 2005-11-17 2013-12-18 バイオミメティック セラピューティクス, インコーポレイテッド rhPDGF−BB及び生体適合性マトリックスを用いた顎顔面骨強化
EP2311505B1 (en) 2006-02-09 2013-11-06 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
EP2049145B1 (en) 2006-06-30 2018-03-14 BioMimetic Therapeutics, LLC Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
AU2007333425B2 (en) 2006-11-03 2014-03-27 Biomimetic Therapeutics, Llc Compositions and methods for arthrodetic procedures
CN105854074B (zh) * 2008-02-07 2019-10-15 生物模拟治疗有限责任公司 用于牵引成骨术的组合物和方法
JP6097479B2 (ja) 2008-05-07 2017-03-15 ボーン セラピューティクス エス.アー. 新規の間葉系幹細胞及び骨形成性細胞
JPWO2010021162A1 (ja) * 2008-08-19 2012-01-26 国立大学法人大阪大学 骨組織再生用の細胞製剤
WO2010030714A2 (en) 2008-09-09 2010-03-18 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
KR101959571B1 (ko) 2010-02-22 2019-03-18 바이오미메틱 세라퓨틱스, 인크. 건 질환의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법
AU2013216173B2 (en) * 2012-02-01 2017-02-16 Organ Technologies, Inc. Dental implant and method for producing same
CN107106492B (zh) 2014-10-14 2022-07-05 塞缪尔·林奇 用于治疗伤口的组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264512A (en) * 1975-09-29 1981-04-28 The Regents Of The University Of California 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
US4861757A (en) * 1986-11-14 1989-08-29 Institute Of Molecular Biology Wound healing and bone regeneration using PDGF and IGF-I
US5124316A (en) * 1986-11-14 1992-06-23 President And Fellows Of Harvard College Method for periodontal regeneration
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
SK136693A3 (en) * 1991-06-05 1994-10-05 Procter & Gamble Therapeutic compositions for osteoinduction
US5129691A (en) * 1991-08-20 1992-07-14 Mcfarlen Jonn Gate latch control device

Also Published As

Publication number Publication date
WO1994022463A1 (en) 1994-10-13
EP0691849B1 (en) 1999-06-02
KR960701648A (ko) 1996-03-28
DK0691849T3 (da) 1999-12-13
RU2140282C1 (ru) 1999-10-27
DE69418865T2 (de) 2000-02-17
ATE180674T1 (de) 1999-06-15
ES2132399T3 (es) 1999-08-16
US5533836A (en) 1996-07-09
AU6417194A (en) 1994-10-24
JP3699111B2 (ja) 2005-09-28
EP0691849A1 (en) 1996-01-17
DE69418865D1 (de) 1999-07-08
JPH08508499A (ja) 1996-09-10
CN1104257C (zh) 2003-04-02
CA2159449C (en) 1999-09-14
CA2159449A1 (en) 1994-10-13
AU681879B2 (en) 1997-09-11
CN1121693A (zh) 1996-05-01

Similar Documents

Publication Publication Date Title
GR3030402T3 (en) Oesteoblast growth stimulating compostion containing pdgf and vitamin d
EP0339607A3 (en) Composition for repair of cartilage and bone and method for their preparation as skeletal tissue implant
AU4381793A (en) Gel composition for implant prosthesis and method of use
EP1142581A3 (en) Tissue sealant and growth factor containing compositions that promote accelerated wound healing
ATE142693T1 (de) Herstellung des vaskulären endothelialen zellwachstumsfaktors
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
ES2007625A6 (es) Un procedimiento para la produccion de una proteina para huesos y cartilagos.
SE9901973D0 (sv) Implantat för applicering i ben och förfarande och användning vid sådant implantat
AU4607885A (en) An implant article for treatment in reconstructive surgery ofdamage caused to bony material
AU7211787A (en) Intraocular dosage compositions and method of use
AU2338497A (en) Conjugated linoleic acid to maintain or enhance bone mineral content
AU1717188A (en) Method of manufacturing synthetic bone coated surgical implants
EP0441639A3 (en) Instrument for the application of controlled mechanical loads to tissues in sterile culture
AU6446490A (en) Disinfectant composition and method of disinfection
AU1520188A (en) Compositions and methods of treatment of timber
ZA881488B (en) New pharmaceutical compositions in the form of beadlets and method
HUT47592A (en) Process for production of derivatives of dideoxicitidin and medical compositions containg them as active substance
ZA989694B (en) Shaped bodies for use as implants in human medicine and method for the production of such shaped bodies
IL97976A0 (en) Composition and method for topical treatment of damaged or diseased tissue containing a mucopolysaccharide
CA2110410A1 (en) Therapeutic Compositions for Osteoinduction
EP0097057A3 (en) Method of producing human epidermal growth factor and pharmaceutical composition containing it
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
EP0347932A3 (en) Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
EP0403530A4 (en) Storage-stable compositions and methods for treating keratinous tissue